{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:08:51Z","timestamp":1783937331348,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.pcl.2016.04.009","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:46:04Z","timestamp":1469526364000},"page":"699-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Endocrine Disorders in Cystic Fibrosis"],"prefix":"10.1016","volume":"63","author":[{"given":"Scott M.","family":"Blackman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2016.04.009_bib1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM199310283291804","article-title":"Correlation between genotype and phenotype in patients with cystic fibrosis. The cystic fibrosis genotype-phenotype consortium","volume":"329","author":"Hamosh","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2016.04.009_bib2","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EJE-14-0644","article-title":"Management of endocrine disease: cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues","volume":"172","author":"Barrio","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pcl.2016.04.009_bib3","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcl.2016.04.009_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","article-title":"Update on cystic fibrosis-related diabetes","volume":"12","author":"Kelly","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.pcl.2016.04.009_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2016.04.009_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcl.2016.04.009_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/jc.2008-2186","article-title":"Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis","volume":"94","author":"Blackman","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pcl.2016.04.009_bib8","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1007\/s00125-009-1436-2","article-title":"A\u00a0susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis","volume":"52","author":"Blackman","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcl.2016.04.009_bib9","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/db13-0510","article-title":"Genetic modifiers of cystic fibrosis-related diabetes","volume":"62","author":"Blackman","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pcl.2016.04.009_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1651-2227.2007.00250.x","article-title":"Liver disease as risk factor for cystic fibrosis-related diabetes development","volume":"96","author":"Minicucci","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.pcl.2016.04.009_bib11","first-page":"1267","article-title":"Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis","volume":"81","author":"Couce","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pcl.2016.04.009_bib12","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/db05-1647","article-title":"Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury","volume":"55","author":"Stalvey","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pcl.2016.04.009_bib13","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1172\/JCI60610","article-title":"Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets","volume":"122","author":"Olivier","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pcl.2016.04.009_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20140059","article-title":"Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass","volume":"128","author":"Uc","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pcl.2016.04.009_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1741-7015-12-87","article-title":"CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells","volume":"12","author":"Edlund","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.pcl.2016.04.009_bib16","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1038\/ncomms5420","article-title":"Glucose-induced electrical activities and insulin secretion in pancreatic islet beta-cells are modulated by CFTR","volume":"5","author":"Guo","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.pcl.2016.04.009_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.pcl.2016.04.009_bib18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201405-0882LE","article-title":"Resolution of cystic fibrosis-related diabetes with ivacaftor therapy","volume":"190","author":"Hayes","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcl.2016.04.009_bib19","article-title":"CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation","author":"Tsabari","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.pcl.2016.04.009_bib20","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the cystic fibrosis foundation, endorsed by the pediatric endocrine society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"Suppl 20","key":"10.1016\/j.pcl.2016.04.009_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pedi.12178","article-title":"ISPAD clinical practice consensus guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents","volume":"15","author":"Moran","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.pcl.2016.04.009_bib22","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.2337\/dc12-1859","article-title":"Hypoglycemia in adults with cystic fibrosis during oral glucose tolerance testing","volume":"36","author":"Hirsch","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcl.2016.04.009_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/er.2015-1026","article-title":"Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge, and future directions","volume":"37","author":"Wong","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pcl.2016.04.009_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(98)70024-1","article-title":"Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition","volume":"132","author":"Lai","year":"1998","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2016.04.009_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1203229","article-title":"Effect of inhaled glucocorticoids in childhood on adult height","volume":"367","author":"Kelly","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2016.04.009_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2265.2002.01484.x","article-title":"The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis","volume":"56","author":"Ripa","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pcl.2016.04.009_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ppul.21127","article-title":"Growth in children with cystic fibrosis-related diabetes","volume":"44","author":"Cheung","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pcl.2016.04.009_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ppul.23042","article-title":"Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis","volume":"50","author":"Bizzarri","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pcl.2016.04.009_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcf.2011.03.003","article-title":"Comparison of height for age and height for bone age with and without adjustment for target height in pediatric patients with CF","volume":"10","author":"Woestenenk","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.pcl.2016.04.009_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF01958975","article-title":"Perspectives of longitudinal growth in cystic fibrosis from birth to adult age","volume":"153","author":"Haeusler","year":"1994","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pcl.2016.04.009_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2005.04.031","article-title":"Gestational and neonatal characteristics of children with cystic fibrosis: a cohort study","volume":"147","author":"Festini","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2016.04.009_bib32","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1073\/pnas.1015281107","article-title":"Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth","volume":"107","author":"Rogan","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.pcl.2016.04.009_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1203\/01.pdr.0000196720.25938.be","article-title":"Mouse as a model of growth retardation in cystic fibrosis","volume":"59","author":"Rosenberg","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pcl.2016.04.009_bib34","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/adc.88.11.956","article-title":"Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients","volume":"88","author":"Sermet-Gaudelus","year":"2003","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.pcl.2016.04.009_bib35","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","author":"Thaker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2016.04.009_bib36","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1542\/peds.2010-2007","article-title":"Recombinant human growth hormone in the treatment of patients with cystic fibrosis","volume":"126","author":"Phung","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2016.04.009_bib37","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2006-1101","article-title":"Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial","volume":"91","author":"Hardin","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pcl.2016.04.009_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.med.0000436191.87727.ec","article-title":"Cystic fibrosis-related bone disease: insights into a growing problem","volume":"20","author":"Stalvey","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.pcl.2016.04.009_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3476(94)70194-6","article-title":"Kyphosis and fractures in children and young adults with cystic fibrosis","volume":"125","author":"Henderson","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2016.04.009_bib40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2265.2008.03216.x","article-title":"Vitamin D and bone health in adults with cystic fibrosis","volume":"69","author":"Wolfenden","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pcl.2016.04.009_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.pcl.2016.04.009_bib42","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2014-1982","article-title":"Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis","volume":"99","author":"Putman","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pcl.2016.04.009_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bone.2004.05.009","article-title":"Prevalence and correlates of vertebral fractures in adults with cystic fibrosis","volume":"35","author":"Rossini","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.pcl.2016.04.009_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00774-014-0572-z","article-title":"Factors associated with low bone mineral density in patients with cystic fibrosis","volume":"33","author":"Sheikh","year":"2015","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.pcl.2016.04.009_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jcf.2013.11.001","article-title":"Recurrent pulmonary exacerbations are associated with low fat free mass and low bone mineral density in young adults with cystic fibrosis","volume":"13","author":"Alicandro","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.pcl.2016.04.009_bib46","first-page":"47","article-title":"Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis","volume":"102","author":"O'Reilly","year":"2009","journal-title":"Ir Med J"},{"key":"10.1016\/j.pcl.2016.04.009_bib47","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.ajpath.2012.01.039","article-title":"The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation","volume":"180","author":"Le Henaff","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pcl.2016.04.009_bib48","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1183\/09031936.00104111","article-title":"Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis","volume":"39","author":"Gimenez-Maitre","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pcl.2016.04.009_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcf.2009.11.005","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone","volume":"9","author":"Le Heron","year":"2010","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.pcl.2016.04.009_bib50","doi-asserted-by":"crossref","first-page":"e80098","DOI":"10.1371\/journal.pone.0080098","article-title":"Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease","volume":"8","author":"Stalvey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pcl.2016.04.009_bib51","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ajpath.2013.12.027","article-title":"Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis","volume":"184","author":"Le Henaff","year":"2014","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.pcl.2016.04.009_bib52","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-015-3343-3","article-title":"Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies","volume":"27","author":"Jacquot","year":"2016","journal-title":"Osteoporos Int"},{"issue":"Suppl 2","key":"10.1016\/j.pcl.2016.04.009_bib53","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.pcl.2016.04.009_bib54","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pcl.2016.04.009_bib55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","article-title":"An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the cystic fibrosis foundation","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pcl.2016.04.009_bib56","article-title":"Treatment of vitamin D deficiency in cystic fibrosis","author":"Chesdachai","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pcl.2016.04.009_bib57","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ppul.20863","article-title":"Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium","volume":"43","author":"Hillman","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pcl.2016.04.009_bib58","series-title":"A\u00a0guide for clinicians","article-title":"Vitamin D and bone health in nutrition in cystic fibrosis","author":"Alvarez","year":"2016"},{"key":"10.1016\/j.pcl.2016.04.009_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-011-1787-7","article-title":"Alcohol and bone: review of dose effects and mechanisms","volume":"23","author":"Maurel","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pcl.2016.04.009_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jcf.2007.07.002","article-title":"Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis","volume":"7","author":"Maqbool","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.pcl.2016.04.009_bib61","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","author":"Conwell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2016.04.009_bib62","first-page":"893589","article-title":"Evaluation of teriparatide for treatment of osteoporosis in four patients with cystic fibrosis: a case series","volume":"2014","author":"Siwamogsatham","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.pcl.2016.04.009_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/S0004-27302010000200007","article-title":"Osteoporosis and inflammation","volume":"54","author":"Lacativa","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.pcl.2016.04.009_bib64","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/eje.0.1480551","article-title":"Sex steroids and body composition in men with cystic fibrosis","volume":"148","author":"Leifke","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pcl.2016.04.009_bib65","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1164\/ajrccm.157.6.9712089","article-title":"Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease","volume":"157","author":"Donovan","year":"1998","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395516300177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395516300177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T15:16:11Z","timestamp":1617635771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395516300177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0031395516300177"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2016.04.009","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Disorders in Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2016.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}